52.JPG)
Global Pediatric Psoriasis Market Size is valued at USD 14.7 Bn in 2024 and is predicted to reach USD 47.7 Bn by the year 2034 at a 12.6% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
Pediatric psoriasis, also known as childhood psoriasis, typically manifests as minor to moderate manifestations and is treatable with treatment. Pediatric psoriasis typically manifests as red, dry, and itchy skin patches, frequent pain, bleeding, and a variety of nail alterations, such as thick, pitted fingernails and nail yellowing. The global pediatric psoriasis market is anticipated to continue growing in revenue due to an increase in regulatory approvals for new and more potent psoriasis medications and treatments. The market has tremendous growth potential that investigators in developing nations have identified. Infantile psoriasis has a relatively limited number of approved therapeutic choices for the pediatric population.
Furthermore, major market competitors are making crucial efforts to diversify their product offerings to increase treatment options. Expanding government endeavors in pediatric psoriasis, rising R&D leading to the release of new medications, improved experience of rare diseases, and cost-effective therapy approaches are the factors driving the market during the projection period. Insufficient data in developing countries and limited funding for research may hinder the market. The market's overall growth is likely constrained by factors including the high cost of pediatric pediatric psoriasis therapies and the availability of resources. Additionally, major market competitors are making crucial efforts to diversify their product offerings to increase treatment options.
The pediatric psoriasis market is segmented based on type, treatment, and end users. Based on type, the market is segmented as plaque psoriasis, guttate psoriasis, pustular psoriasis, inverse psoriasis, erythrodermic psoriasis, mucosal/oral psoriasis, nail psoriasis, napkin or diaper psoriasis, photosensitive psoriasis, flexural psoriasis. By application, the market is segmented into topical therapy, oral injections, biologics, natural supplements, and phototherapy. By end users, the market is segmented as hospitals, specialty clinics, ambulatory care centers, and research organizations.
The plaque psoriasis sector is anticipated to have the biggest market share over the projection period. This is explained by the fact that children have the highest disease incidence. It is also the most prevalent type of psoriasis. These plaques appear most frequently on the knees, scalp, and elbows. These, though, can also be found in other bodily areas. These can hemorrhage and are unpleasant, irritating, and uncomfortable. It is unclear what specifically causes plaque psoriasis.
The hospital segment is projected to grow at a rapid rate in the global pediatric psoriasis market. The increased adoption of therapies and widespread hospital use contribute to the growth. Therefore, researchers would have a favorable market impact by developing potent, secure drugs and dosages. One of the main drivers of this segment's revenue growth is the rise in pediatric psoriasis instances that are severe, the rate of hospital admissions, and the quick acceptance of safer and more effective medications and therapies., especially in countries such as the US, Germany, UK, China, and India.
The North American pediatric psoriasis market is expected to register the highest market share in revenue soon. Due to the rising prevalence of the condition, North America now controls the plaque psoriasis market. Additionally, a potent drug pipeline in the region would help the pediatric psoriasis market throughout the projection period.
Asia Pacific region is estimated to hold a significant share of the market. The pediatric psoriasis market is anticipated to experience considerable expansion in Asia-Pacific because of the rise in research investment. Moreover, the region's plaque psoriasis market is anticipated to rise over the next several years because of growing public awareness of the condition.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 14.7 Billion |
|
Revenue Forecast In 2034 |
USD 47.7 Billion |
|
Growth Rate CAGR |
CAGR of 12.6% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn,and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type, Treatment, End-Use |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
AbbVie Inc., Amgen Inc, Johnson & Johnson, Novartis AG, Eli Lilly & Company, AstraZeneca, Celgene Corporation, UCB, Merck, Boehringer Ingelheim, LEO Pharma, Other Prominent Players. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Pediatric Psoriasis Market Snapshot
Chapter 4. Global Pediatric Psoriasis Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type:
5.2.1. Plaque psoriasis
5.2.2. Guttate psoriasis
5.2.3. Pustular psoriasis
5.2.4. Inverse psoriasis
5.2.5. Erythrodermic psoriasis
5.2.6. Mucosal/oral psoriasis
5.2.7. Nail psoriasis
5.2.8. Napkin or diaper psoriasis
5.2.9. Photosensitive psoriasis
5.2.10. Flexural psoriasis
Chapter 6. Market Segmentation 2: by Treatment Estimates & Trend Analysis
6.1. by Treatment & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Treatment:
6.2.1. Topical therapy
6.2.2. Oral
6.2.3. Injections
6.2.4. Biologics
6.2.5. Natural supplements
6.2.6. Phototherapy
Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis
7.1. by End-user & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-user:
7.2.1. Hospitals
7.2.2. Specialty Clinics
7.2.3. Ambulatory Care Centers
7.2.4. Research Organizations
Chapter 8. Pediatric Psoriasis Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by Estimates and Forecasts by Type, 2021-2034
8.1.2. North America Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by Estimates and Forecasts by Treatment, 2021-2034
8.1.3. North America Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by End-user, 2021-2034
8.1.4. North America Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by Type, 2021-2034
8.2.2. Europe Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by Treatment, 2021-2034
8.2.3. Europe Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by End-user, 2021-2034
8.2.4. Europe Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by Type, 2021-2034
8.3.2. Asia Pacific Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by Treatment, 2021-2034
8.3.3. Asia-Pacific Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by End-user, 2021-2034
8.3.4. Asia Pacific Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by Type, 2021-2034
8.4.2. Latin America Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by Treatment, 2021-2034
8.4.3. Latin America Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by End-user, 2021-2034
8.4.4. Latin America Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by Type, 2021-2034
8.5.2. Middle East & Africa Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by Treatment, 2021-2034
8.5.3. Middle East & Africa Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by End-user, 2021-2034
8.5.4. Middle East & Africa Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. AbbVie Inc.
9.2.2. Amgen Inc
9.2.3. Johnson & Johnson
9.2.4. Novartis AG
9.2.5. Eli Lilly & Company
9.2.6. AstraZeneca
9.2.7. Celgene Corporation
9.2.8. UCB
9.2.9. Merck
9.2.10. Boehringer Ingelheim
9.2.11. LEO Pharma
9.2.12. Other Prominent Players
By Type
By Treatment
Bend Use
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
